Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Clare Slaney

Senior Research Fellow

Peter MacCallum Cancer Institute

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Xin Du

Monash Biomedicine Discovery Institute, Monash University

AUSTRALIA

View details

Misty Rayna Jenkins

Lab Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

David Ritchie

Head of BMT

AUSTRALIA

View details

anthony jaworowski

Associate Dean, HDR. Associate Professor

RMIT University

AUSTRALIA

View details

Colin Pouton

MONASH UNIVERSITY

AUSTRALIA

View details

Paul Ekert

Group Leader, Translational Tumour Biology

Children's Cancer Institute Australia

AUSTRALIA

View details

Wayne Phillips

Adjunct Professor

Monash Health

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Clare Slaney

Research Interests

Explore related searches

Articles (11)

Rewiring immunity with in vivo CAR T cell engineering

Parallel processing of T cells and natural killer cells to enhance in vivoCAR T cell activity against blood and solid cancers

Ironing out a metabolic barrier to durable CAR T cell therapy

Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models

Optimised modular anti‐FLAG CAR T cells for solid tumor therapy

Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals

FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.

YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells

T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.

Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges

Editorial: Combining chemo/radio therapy and immunotherapy for cancers-perfect mix of old and new.

Collaborators (7)

Xin Du

Misty Rayna Jenkins

David Ritchie

anthony jaworowski

Colin Pouton

Paul Ekert

Wayne Phillips

Make your next move.